Aprepitant and fosaprepitant use in children and adolescents at an academic medical center (Q38229576)

31 August 2017

Aprepitant and fosaprepitant use in children and adolescents at an academic medical center (English)

1 reference

31 August 2017

Alexandra Shillingburg

series ordinal

1 reference

PMC publication ID

4093665

31 August 2017

Lisa Biondo

series ordinal

1 reference

31 August 2017

1 April 2014

1 reference

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

31 August 2017

1 reference

31 August 2017

1 reference

31 August 2017

1 reference

31 August 2017

127-131

1 reference

Antiemetics: American Society of Clinical Oncology clinical practice guideline update

31 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Aprepitant Use in Children, Adolescents, and Young Adults for the Control of Chemotherapy-Induced Nausea and Vomiting (CINV)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Acute and delayed nausea and emesis control in pediatric oncology patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Anticipatory nausea and vomiting in pediatric cancer patients: an analysis of conditioning and coping variables

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Stability of an extemporaneous oral liquid aprepitant formulation

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4093665

10.5863/1551-6776-19.2.127

31 August 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference

PMC publication ID

4093665

31 August 2017

PubMed publication ID

25024673

1 reference

PMC publication ID

4093665